Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2005
11/02/2005EP1590326A2 Substituted alkyl amido piperidines
11/02/2005EP1590324A1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb
11/02/2005EP1589970A2 Pharmaceutical compositions comprising thieno [2,3-c]pyridine deritives and use thereof
11/02/2005EP1589930A2 Combination therapy for anticoagulation
11/02/2005EP1589815A2 POLYCOSANOLS FROM i ERICERUS PELA /i WAX
11/02/2005EP1507758B1 Indole derivatives and their use as ligands for cb2 receptors
11/02/2005EP1427415A4 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
11/02/2005EP1368056B1 Recombinant gelatin-like proteins for use as plasma expanders
11/02/2005EP1332149B1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
11/02/2005EP1311501B1 Antithrombotic agents
11/02/2005EP1237902B1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
11/02/2005EP1117443B1 Peptide-based carrier devices for stellate cells
11/02/2005EP1102767B1 Substituted pyrazole derivatives
11/02/2005EP1080095B1 Modulators of protein tyrosine phosphatases (ptpases)
11/02/2005CN1691959A Interleukin 6 production inhibitor
11/02/2005CN1691945A Use of rapamycin for inhibiting of cell death
11/02/2005CN1689563A Application of butylbenzene phthalein homolog in preparation of medicine for treating cerebral ischemia disease
11/02/2005CN1225459C NItroxyderivatives having antiinflammatory, analgesic and antithrombotic activity
11/02/2005CN1225276C Preparation method of red peony root injection
11/02/2005CN1225262C Chinese medicine capsule for treating hemopathy and its prepn.
11/01/2005US6960609 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
11/01/2005US6960605 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
11/01/2005US6960587 Piperido(1,2-a)piperazine-1,4-dione derivatives fused to a 5-7 membered ring at the 7-8 position; cGMP-specific PDE inhibitors; treatment of cardiovascular disorders and erectile dysfunction.
11/01/2005US6960582 Such as (3S)-N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-((1S,2S,3S,5R)-2,6,6-trimethylbicyclo(3.1.1)hept-3 -yl)piperazine-1-carboximidamide for treatment of obesity or type II diabetes
11/01/2005US6960581 1-amino-2-hydroxy-butane or 2-hydroxy-butanamide derivatives
10/2005
10/27/2005WO2005100987A1 Novel ligand of g protein coupled receptor protein and use thereof
10/27/2005WO2005100570A1 Earthworm fribrinolytic enzyme gene, genetic engineering strains, and the construction and usages thereof
10/27/2005WO2005100563A1 Follistatin mutant polypeptide
10/27/2005WO2005099760A1 Solid pharmaceutical preparation
10/27/2005WO2005099759A1 Medicine for prevention and/or treatment of arteriosclerosis
10/27/2005WO2005099736A1 Antitumor remedy
10/27/2005WO2005099671A2 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/27/2005WO2004068109A3 Autologous or homologous coagulant produced from anticoagulated whole blood
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239852 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/27/2005US20050239851 Substituted benzoxazoles as estrogenic agents
10/27/2005US20050239835 controlling weight gain; 1-(1-amino-2-phenylethylcarbonyl)-4-cyclohexylpiperidine compounds
10/27/2005US20050239789 2-(9-bromo-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indol-2-yl)-cyclobutanone; treating disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea
10/27/2005US20050239776 Tachykinin receptor antagonists
10/27/2005US20050239686 Methods and compositions for optimization of oxygen transport by cell-free systems
10/27/2005US20050239171 Method for purifying factor VIII/vWF-complex by means of cation exchange chromatography
10/27/2005US20050239141 Modified antibody variable domains
10/27/2005US20050239131 Interactive system for presenting and eliminating substances
10/27/2005US20050238720 Stable pharmaceutical composition comprising erythropoietin
10/27/2005US20050238578 Administering anticarcinogenic agent and chelate complex of macrocyclic aminophosphonic acid and radionuclide such as samarium ethylenediaminetetramethylenephosphonic acid (EDTMP) to replace total body irradiation;antiproliferative agents; autoimmune, infectious, metabolic or genetic disorders
10/27/2005CA2563689A1 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/27/2005CA2563408A1 Annexin v for preventing atherothrombois and plaque rupture
10/27/2005CA2562885A1 Follistatin variant polypeptide
10/27/2005CA2562391A1 Solid pharmaceutical preparation
10/27/2005CA2559568A1 Materials and methods for treating coagulation disorders
10/27/2005CA2505469A1 Drug delivery device comprising a bilayered polymeric coating having a cell cycle inhibitor that acts selectively at the g1 phase of the cell cycle incorporated into the first polymer coating layer
10/26/2005EP1589029A2 Pyrazinone protease inhibitors
10/26/2005EP1588727A1 Drug/drug delivery systems for the prevention and treatment of vascular disease
10/26/2005EP1588726A1 Drug/drug delivery systems for the prevention and treatment of vascular disease
10/26/2005EP1587838A2 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation
10/26/2005EP1397354B1 Imidazole-2-carboxamide derivatives as raf kinase inhibitors
10/26/2005EP1381607B1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepine-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/26/2005EP0984785B1 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
10/26/2005EP0506757B2 A recombinant human factor viii derivative
10/26/2005CN1688603A Treatment and prophylaxis with 4-1BB-binding agents
10/26/2005CN1688548A Process for preparing quinolin antibiotic intermediates
10/26/2005CN1688332A Propagation increasing action of osteogenic growth peptide to hemopoietic progenitor cell and application
10/26/2005CN1688325A Black soybean polysaccharides
10/26/2005CN1688300A Peritoneal dialysate containing taurine
10/26/2005CN1224707C Intracellular isoform of the interleukin-1 receptor antagonist
10/26/2005CN1224629C Phrazinone protease inhibitors
10/26/2005CN1224627C Modified factor VIII
10/26/2005CN1224626C Beta-D-5-thioxylose derivatives, preparation method and therapeutic use
10/26/2005CN1224623C 1-phenysulfonyl-1, 3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use
10/26/2005CN1224598C Naphthalene derivatives
10/26/2005CN1224423C Pharmaceutical composition improved in peroral absorbability
10/26/2005CN1224421C Novel specific mechanism for inhibiting adherence of platelets to collagen
10/26/2005CN1224404C Onion extract with controlling action for angiocardiopathy
10/26/2005CN1224393C Process for preparing selenium aspirin enteric tablet and its use of resisting thrombosis
10/25/2005US6958387 Human serpin polypeptides
10/25/2005US6958357 Central nervous system disorders; antiallergens; respiratory system disorders
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005US6958344 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/25/2005US6958331 sulfonyl amine derivatives such as {2-(2,2-diphenyl-ethylamino)-5-[4-(4-isopropyl-piperazine-1-carbonyl)-piperidine-1-sulfonyl]-phenyl}-morpholin-4-yl-methanone; pain, inflammation, septic shock
10/25/2005US6958164 Antithrombotic agents
10/25/2005CA2332461C New benzenesulfonamide derivatives, their method of preparation and the pharmaceutical compositions containing them
10/21/2005CA2504582A1 Drug delivery device comprising a bilayered polymeric coating having an inhibitor of the mamalian target of rapamycin incorporated into the first polymeric coating layer
10/21/2005CA2504401A1 Drug delivery systems for the prevention of neointimal hyperlasia
10/20/2005WO2005097814A2 Composition and method for inhibiting platelet aggregation
10/20/2005WO2005097152A1 Turmeric extract-containing composition having improved caking capacity
10/20/2005US20050234245 Estrogen receptor modulators
10/20/2005US20050234116 e.g. 4-(4-chlorophenyl)-2-(2-methyl-1-imidazolyl)-5-[3-(2-methylphenoxy)propyl]oxazole; voltage-dependent anion channel, mitochondria porin modulator, apoptosis suppressor, mitochondria function ameliorator; Down syndrome, pigmentary degeneration of retina, alcoholic hepatitis or sideroblastic anemia
10/20/2005US20050234104 Dabigatran etexilate mesylate polymorph, crystalline form of a prodrug used for post-operative prophylaxis of deep vein thrombosis and the prevention of a stroke; stability; solubility; reproduciblity; hydrophobic; pharmacological potency; low amorphization during grinding and compression
10/20/2005US20050234088 Urea substituted imidazoquinoline ethers
10/20/2005US20050234081 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
10/20/2005US20050234079 Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy] benzyl]thiazolidine-2,4-dione potassium salt
10/20/2005US20050234077 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/20/2005US20050234063 Therapeutic agent for brain hemorrhage
10/20/2005US20050234062 Such as 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-2H-acetamide; phosphodiesterase inhibitors; for treatment of respiratory disorders
10/20/2005US20050234041 Substituted 1-benzazepines and derivatives thereof
10/20/2005US20050234035 New salts
10/20/2005US20050234017 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
10/20/2005US20050234015 Low molecular weight heparin salt with triethanolamine useful as therapeutic-antitrombotic agent of local delivery, procedures for preparing them, process for elimination of hygroscopicity of heparin salt, pharmaceutical compositions for local use in antithrombotic therapy and uses therein
10/20/2005US20050233992 Regeneration of endogeneous myocardial tissue by induction of neovascularization
10/20/2005US20050233956 Proteins involved in the regulation of energy homeostasis
1 ... 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 ... 671